BrainsWay 2021 logo.jpg
Brainsway's Deep TMS System to be Marketed and Distributed in Nordic Countries
23 oct. 2012 10h05 HE | BrainsWay Ltd.
JERUSALEM, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce the execution of an agreement for the marketing and distribution of its Deep TMS device in Nordic...
BrainsWay 2021 logo.jpg
Brainsway Starts Multicenter Clinical Trial for Bipolar Disorder
21 août 2012 09h21 HE | BrainsWay Ltd.
JERUSALEM, Aug. 21, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (BRIN.TA) is pleased to announce that, further to its press release of November 1, 2011, the Company has contracted with 18 medical research...
BrainsWay 2021 logo.jpg
Israel Ministry of Health Approves Brainsway Clinical Trial for Autism
24 juil. 2012 15h32 HE | BrainsWay Ltd.
JERUSALEM, July 24, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received approval from Israel's Ministry of Health to test the efficacy of its Deep TMS...
BrainsWay 2021 logo.jpg
Brainsway Reports Positive Preliminary Results of Study Using Deep TMS to Treat OCD
03 juil. 2012 08h24 HE | BrainsWay Ltd.
JERUSALEM, July 3, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results with respect to a clinical trial being conducted at the Sheba Medical...
BrainsWay 2021 logo.jpg
Brainsway Receives CE Mark Approval for Its Deep TMS System to Treat Neuropathic Chronic Pain
02 juil. 2012 16h05 HE | BrainsWay Ltd.
JERUSALEM, July 2, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received CE Mark enabling commercialization of its Deep TMS system to treat neuropathic...
BrainsWay 2021 logo.jpg
Brainsway Reports Positive Pivotal Multicenter Major Depression Trial Results
18 avr. 2012 10h17 HE | BrainsWay Ltd.
JERUSALEM, April 18, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce positive results from its double-blind multicenter clinical trial for the assessment of the safety and...
BrainsWay 2021 logo.jpg
Brainsway Receives Prestigious Frost & Sullivan 2012 New Product Innovation Award
23 févr. 2012 16h22 HE | BrainsWay Ltd.
JERUSALEM, Feb. 23, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received the Frost & Sullivan 2012 Global New Product Innovation Award in...
BrainsWay 2021 logo.jpg
Brainsway Reports Positive Final Results of Study Using Deep TMS to Open the Blood-Brain Barrier in Patients With Brain Tumors
21 févr. 2012 08h40 HE | BrainsWay Ltd.
JERUSALEM, Feb. 21, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received the final results of a clinical trial performed by Advanced Technologies Innovation...
BrainsWay 2021 logo.jpg
Brainsway Signs Agreement for Distribution and Sale of Deep TMS Device in Chile
03 janv. 2012 09h00 HE | BrainsWay Ltd.
JERUSALEM, Jan. 3, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that, on January 1st, 2012, it entered into an exclusive agreement for the distribution of the Deep TMS...
BrainsWay 2021 logo.jpg
Brainsway Announces Interim Results in Multiple Sclerosis Clinical Trial
28 déc. 2011 14h23 HE | BrainsWay Ltd.
JERUSALEM, Dec. 28, 2011 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results with respect to 26 patients from a double-blinded clinical trial...